Skip to Page Content
Start-Up
SUBSCRIBE

Start-Up

In-depth profiles of leading-edge companies and technologies, including the most important new trends in the biopharma, medtech and diagnostics industries.

About | Staff | Free Trial | Advertise

START-UP is the most respected resource on emerging technologies, companies and investment opportunities available today, uncovering life science’s newest technologies, promising trends and powerful ideas.

START-UP delivers new markets, technologies, investments, partners, financing sources and incredibly rich deals data across the biopharma, device and diagnostic industries. START-UP profiles the most important new products and companies, identifies the hottest technology areas, reviews funds flowing into private companies and investment trends, and reports on university tech transfer licensing.

START-UP delivers:

  • Complete data and expert analysis on the technology, science, management and potential of the hottest start-ups around the world, helping you find new partners and identify exciting new investments ahead of the competition 
  • In-depth analysis that gives you the big picture, not just the headlines 
  • Key trends that will guide your business development strategy 
  • Strategies that work and strategies that don't; including follow-ups on previously profiled companies 
  • Abundant deals data to help you accurately value your new product and approach the negotiating table with confidence 
  • Tech transfers to help you discover potential blockbusters emerging under the radar from academia 
  • Promising science that isn’t even on the ground floor yet with our unique Science Matters column

 

Your START-UP subscription will include:

  • 11 monthly issues: Including a combined July-August issue
  • Online access: Searchable access to a rolling 90 or 365 days of content
  • Archives: Available access to the information you need from our complete archive
  • Daily online news resource: A free subscription to Health News Daily, our online resource for news in pharmaceutical, biotechnology, medical devices, and Washington Health policy
Subscription Terms

Subscription Options

Buy Now

Includes: Email newsletter with latest headlines, breaking news alerts, and access to START-UP — in-depth profiles of leading-edge companies and technologies, including the most important new trends in the biopharma, medtech and diagnostics industries.

Multiple users/site features: Contact Deanna Flanick at +1-908-547-2141 or D.Flanick@Elsevier.com.